| 37.1 -0.06 (-0.16%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 45.18 | 1-year : | 52.78 |
| Resists | First : | 38.68 | Second : | 45.18 |
| Pivot price | 37.46 |
|||
| Supports | First : | 36.61 | Second : | 35.34 |
| MAs | MA(5) : | 37.21 |
MA(20) : | 37.23 |
| MA(100) : | 35.59 |
MA(250) : | 33.83 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 35.7 |
D(3) : | 41.7 |
| RSI | RSI(14): 52.4 |
|||
| 52-week | High : | 38.68 | Low : | 28.15 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ PINK ] has closed above bottom band by 29.8%. Bollinger Bands are 31.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 37.54 - 37.72 | 37.72 - 37.87 |
| Low: | 36.52 - 36.78 | 36.78 - 36.98 |
| Close: | 36.75 - 37.13 | 37.13 - 37.44 |
The Simplify Health Care ETF, identified by its symbol PINK, is engineered to generate significant long-term capital appreciation. It offers investors diversified exposure to pioneering and innovative companies of varying market capitalizations across crucial healthcare sub-sectors, including biotechnology, medical technology, gene therapy, and other rapidly expanding health-related industries. The fund is expertly managed by Michael Taylor, who serves as the lead portfolio manager, bringing more than two decades of specialized experience in overseeing long/short healthcare equity portfolios for prominent hedge funds. A distinguishing feature of PINK is its status as the first entirely pro bono ETF focused on the healthcare sector. All net profits generated by the fund are pledged for annual donation to the Susan G. Komen foundation, embodying its mission: "PINK: Shares for the Cure." As of September 1, 2025, these charitable contributions have amounted to $350,000.
Sun, 14 Jun 2026
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - AOL.com
Wed, 10 Jun 2026
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - The Motley Fool
Sat, 06 Jun 2026
Trading the Move, Not the Narrative: (PINK) Edition - Stock Traders Daily
Fri, 05 Jun 2026
XLV vs. PINK Healthcare ETF Comparison: Cost, Performance, and Portfolio - News and Statistics - IndexBox
Fri, 05 Jun 2026
Healthcare Giants or Medical Innovators? XLV and PINK Are Built for Different Investors. - The Motley Fool
Tue, 02 Jun 2026
Vanguard (VHT) Vs. Simplify (PINK): Which Healthcare ETF Is the Better Buy for Investors? - AOL.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|